Efficacy of vitamin E and vitamin C in the treatment of nonalcoholic steatohepatitis

Practical Gastroenterology

Volumn 34, Issue 5, 2010, Pages 20-27

  Patel, Kaushik ^a   Babich, Michael ^b  

^a St Dominic Jackson Memorial Hospital   (United States)

^b DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ALPHA TOCOPHEROL; AMINOTRANSFERASE; ASCORBIC ACID; ASPARTATE AMINOTRANSFERASE;

ADULT; AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BODY WEIGHT; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG MEGADOSE; FEMALE; FOLLOW UP; HUMAN; LIVER BIOPSY; MALE; MEDICAL RECORD REVIEW; NONALCOHOLIC FATTY LIVER; OXIDATIVE STRESS; PATHOGENESIS; PATIENT CODING; RETROSPECTIVE STUDY; STEATOSIS; THEORY;

EID: 77957604741     PISSN: 02774208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. McCullough AJ. Pathophysiology of nonalcoholic steatohepatitis. J Clin Gastroenterol, 2006;40:S17-S29.
2. McCullough AJ. The epidemiology and risk factors of NASH. In: Farrell GC, George J, Hall P, et al, eds. Fatty Liver Disease: NASH and Related Disorders. Oxford: Blackwell, 2005:23-37.
3. Falck-Ytter Y, McCullough AJ. Clinical features and natural history of nonalcoholic steatosis. Semin Liver Dis, 2001;21:17-26.
4. Mulhall BP, Younossi ZM. Nonalcoholic steatohepatitis. Curr Treat Options Gastroenterol, 2004;7:423-430.
5. Ludwig J, Viggiano TR, McGill DB, et al. Nonalcoholic steatohepatitis. Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc, 1980;55:434-438.
6. Jansen PLM. Nonalcoholic steatohepatitis. Neth J Med, 2004;62:217-224.
7. McClain CJ, Barve S, Deaciuc I. Good fat/bad fat. Hepatology, 2007;45:1343-1346.
8. Bayard M, Holt J, Boroughs E. Nonalcoholic fatty liver disease. Am Fam Physician, 2006;73:1961-1968.
9. Ramesh S, Sanyal AJ. Evaluation and management of non-alcoholic steatohepatitis. J Hepatol, 2005;42:S2-S12.
10. Kugelmas M, Hill DB, Vivian B, et al. Cytokines and NASH: a pilot study of the effects of lifestyle modification and vitamin E. Hepatology, 2003;38:413-419.
11. Chan AC. Partners in defense, vitamin E and vitamin C. Can J Pharmacol, 1993:71:725-731.
12. Brunt EM, Janney CG, Di Bisceglie AM, et al. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol, 1999;94:2467-2474.
13. Miller ER, Pastor-Barriuso R, Dalal, D, et al. Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality. Ann Intern Med, 2005;142:37-46.
14. Stengel JZ, Harrison SA. Nonalcoholic steatohepatitis: clinical presentation, diagnosis, and treatment. Gastroenterol Hepatol, 2006;2:440-449.
15. Harrison SA. New treatments for nonalcoholic fatty liver disease. Curr Gastroenterol Rep, 2006;8:21-29.
16. Harrison SA, Torgerson S, Hayashi P, et al. Vitamin E and vitamin C treatment improves fibrosis in patients with nonalcoholic steatohepatitis. Am J Gastroenterol, 2003;98:2485-2490.
17. Kawanaka M, Mahmood S, Niiyama G, et al. Control of oxidative stress and reduction in biochemical markers by vitamin E treatment in patients with nonalcoholic steatohepatitis: a pilot study. Hepatol Res, 2004;29:39-41.
18. Ersoz G, Gunsar F, Karasu Z, et al. Management of fatty liver disease with vitamin E and C compared to ursodeoxycholic acid treatment. Turk J Gastroenterol, 2005;16:124-128.
19. Dufour J, Oneta CM, Gonvers J, et al. Randomized placebo controlled trial of ursodeoxycholic acid with vitamin E in nonalcoholic steatohepatitis. Clin Gastroenterol Hepatol, 2006;4:1537-1543.
20. Sanyal AJ, Mofrad PS, Contos MJ, et al. A pilot study of vitamin E versus vitamin E and pioglitazone for the treatment of nonalcoholic steatohepatitis. Clin Gastroenterol Hepatol, 2004;2:1107-1115.